MDxHealth Announces Completion of Initial Public Offering of ADSs in the United States
NEWS RELEASE - REGULATED INFORMATION
NOVEMBER 8, 2021, 22:30 CET
MDxHealth Announces Completion of Initial Public Offering of ADSsin the United States
IRVINE, CA, and HERSTAL, BELGIUM – November 8, 2021 – MDxHealth SA (Nasdaq and Euronext Brussels: MDXH) ("MDxHealth" or the "Company"), a commercial-stage precision diagnostics company, today announces, in accordance with Article 15 of the Belgian Act of 2 May 2007 on the disclosure of major participations in issuers of which shares are admitted to trading on a regulated market and regarding miscellaneous provisions, that in the context of the capital increase that was announced on October 28, 2021 and completed on November 8, 2021 by means of an initial public offering in the United States of 3,750,000 American Depositary Shares (each representing 10 ordinary shares of the Company with no nominal value per share), its share capital has increased from EUR 90,132,067.69 to EUR 118,662,067.69 and the number of issued and outstanding shares has increased from 118,469,226 to 155,969,226 ordinary shares, through the issuance of a total of 37,500,000 new shares. In addition to the outstanding shares, the total number of outstanding subscription rights on the moment of this press release amounts to 9,487,968, which entitles their holders (assuming all subscription rights are granted and exercised) to subscribe to 9,487,968 new shares with voting rights in total.
MDxHealth is a commercial-stage precision diagnostics company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The Company's tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers and prognosis of recurrence risk. The Company's European headquarters are in Herstal, Belgium, with laboratory operations in Nijmegen, The Netherlands, and U.S. headquarters and laboratory operations based in Irvine, California. For more information, visit mdxhealth.com and follow us on social media at: twitter.com/mdxhealth, facebook.com/mdxhealth and linkedin.com/company/mdxhealth.
For more information:
NOTE: The MDxHealth logo, MDxHealth, ConfirmMDx and SelectMDx are trademarks or registered trademarks of MDxHealth SA ("MDxHealth"). All other trademarks and service marks are the property of their respective owners.
AttachmentTo view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Ultimovacs ASA: Mandatory notification of trade by primary insider2.12.2021 16:30:00 CET | Press release
Oslo, 2 December 2021, Carlos de Sousa, Chief Executive Officer and primary insider in Ultimovacs ASA, has today bought 1,000 shares in the company at a price of NOK 107.60 per share. Following this transaction, Carlos de Sousa and closely related parties hold 15,056 shares and 416,035 share options in Ultimovacs ASA. This information is subject to the disclosure requirements pursuant to the Market Abuse Regulation article 19 and section 5-12 of the Norwegian Securities Trading Act. Attachment 20211221 - Ultimovacs Notification of trade - KRT-1500
Connecterra and Lely Announce Strategic Partnership2.12.2021 15:05:00 CET | Press release
Following the completion of a successful pilot, the two companies will deepen their collaboration and commercial relationship Amsterdam, The Netherlands, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Today Dutch-based startup, Connecterra, a world leader in using artificial intelligence to deliver insights to farmers, and Lely, the global leading supplier of robotics and management systems for dairy farming, announced the start of a robust co-development and commercial partnership. The announcement follows a pilot with Lely’s Digital Farming Group. The pilot program was designed to test an integration between Lely Horizon and Connecterra’s artificial intelligence platform, Ida. The successful effort has resulted in commitments to several strategic initiatives. As a first step in the agreement, Lely will now license Ida Enterprise for use in their farm management system Lely Horizon. “We believe that digitization of dairy farming is key and needs to be handled with care. Integrating with partners l
Fobi Announces Signing Of Amazon Fulfillment And Business Seller Agreement2.12.2021 13:45:00 CET | Press release
Fobi’s hardware and software solutions will now be available on Amazon Business, reaching over five million businesses worldwide VANCOUVER, British Columbia, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Fobi AI Inc. Inc.(FOBI:TSXV FOBIF:OTCQB) (the “Company” or “Fobi”), a leader in providing real-time data analytics through artificial intelligence to drive customer activation and engagement, announced it has signed an agreement with Amazon for distribution and fulfillment of Fobi AI’s various hardware products. As part of the agreement, Fobi will also become an Amazon Business Seller which will enable Fobi to gain access to Amazon’s global e-commerce, logistics and fulfillment infrastructure. By joining Amazon Business, Fobi immediately reaches over 5 million business customers in nine countries: a network that Fobi is very proud to now be included in. Fobi will now generate additional revenue through hardware, products and services sold on Amazon Business. Fobi will be launching their Fobi 3.0 I
Mandalay Resources Corporation Completes Sale of Cerro Bayo Mine to Equus Mining2.12.2021 13:30:00 CET | Press release
TORONTO, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Mandalay Resources Corporation ("Mandalay" or the "Company") (TSX: MND, OTCQB: MNDJF) is pleased to announce that it has completed the previously announced sale of its Cerro Bayo mine in Region XI, Southern Chile (see Mandalay press releases dated October 12, 2021, and October 8, 2019). Pursuant to the transaction, Equus Mining Limited (“Equus”) acquired the Cerro Bayo mine, including its mining properties, resources and mine infrastructure as well as a 1,500 tonnes per day processing plant, in exchange for 587,502,438 ordinary shares in the capital of Equus. Mandalay also retains a 2.25% net smelter royalty on production from the Cerro Bayo mining claims once the mine has produced at least 50,000 ounces of gold equivalent, subject to a re-purchase option in favour of Equus, and remains responsible for 50% of approved site closure costs at Cerro Bayo. In addition, Equus will appoint Ryan Austerberry, Mandalay’s Costerfield mine General Manager
CTG and Micro Focus Extend European Platinum Partnership to French Market2.12.2021 12:55:00 CET | Press release
PARIS, Dec. 02, 2021 (GLOBE NEWSWIRE) -- CTG (NASDAQ: CTG), a leading provider of digital IT services and solutions in North America and Western Europe, today announced an expanded strategic partnership agreement with Micro Focus to now include CTG France. The partnership aligns CTG’s testing capabilities with Micro Focus’ Application Lifecycle Management (ALM) software to help clients accelerate their software delivery and ensure quality and application performance at every stage of the digital application lifecycle. Leveraging the global organization’s decades of experience, a team of more than 500 testers, and a network of more than 3,000 crowdtesters, CTG France offers its clients comprehensive Application Testing Solutions. The Company’s Testing Solutions portfolio includes advisory consulting, test methodology and process, performance testing, manual functional testing, testing automation, test tool implementation, and crowdtesting. Many of CTG’s more than 400 clients use Micro F
WESTPAY AND EASYCASHIER COMPLETE SUCCESSFUL LAUNCH OF MULTI-USER PAYMENT SOLUTION2.12.2021 12:45:00 CET | Press release
Westpay AB, a leading fintech company, has enabled multi-user functionality (MultiTID) in their payment application. This solution makes it possible for several users to share a physical payment solution. This is in demand in several verticals, such as hairdressers, who share premises but run their business individually. EasyCashier, a leading POS provider and a close partner to Westpay will be the first partner that offer this solution for their customers. - Again, I am proud that Westpay continues to push the limits to what you can expect from a payment solution.We have seen this functionality before, but the way we manage to simplify the use of sharing payment solutions. It is also happy that EasyCashier embraces this solution and enables it for their customers. They are a solid, reliable partner with great expertise and experience, says Hans Edin, CCO at Westpay. - Quality and innovation are two vital features for us at EasyCashier. We always try to level up the value as well as th
TGS Share Repurchase2.12.2021 10:57:49 CET | Press release
Oslo, Norway (02 December 2021) – On period from 25 November 2021 to 01 December 2021, TGS ASA (TGS) purchased 67,328 own shares on the Oslo Stock Exchange at an average price of NOK 85.1890 per share. Following the purchase TGS owns 1,226,303 shares, representing 1.044% of the total outstanding shares. The shares were purchased in connection with the share repurchase announced on 11 February 2021. Overview of transactionsDateAggregated daily volume (number of shares)Weighted average share price per day (NOK)Total daily transaction value (NOK)25-Nov-2110,87888.9977968,11726-Nov-2120,00084.97931,699,58629-Nov-212,00084.2400168,48030-Nov-2120,00084.16361,683,2721-Dec-2114,45084.16241,216,147Previously disclosed buy-backs under the program (accumulated)1,143,975105.5774120,777,940Accumulated under the buy-back program1,211,303104.4442126,513,541The issuer's holding of own shares:Following the completion of the above transactions, TGS owns a total of 1,226,303 own shares, corresponding to